Search Results - "BOURREILLE, A"

Distinct expression of interleukin (IL)‐36α, β and γ, their antagonist IL‐36Ra and IL‐38 in psoriasis, rheumatoid arthritis and Crohn's disease by Boutet, M.‐A., Bart, G., Penhoat, M., Amiaud, J., Brulin, B., Charrier, C., Morel, F., Lecron, J.‐C., Rolli‐Derkinderen, M., Bourreille, A., Vigne, S., Gabay, C., Palmer, G., Le Goff, B., Blanchard, F.

“…Summary Interleukin (IL)‐36α, IL‐36β and IL‐36γ are expressed highly in skin and are involved in the pathogenesis of psoriasis, while the antagonists IL‐36Ra…”
Get full text

Resilience of the Dominant Human Fecal Microbiota upon Short-Course Antibiotic Challenge by DE LA COCHETIERE, M. F, DURAND, T, LEPAGE, P, BOURREILLE, A, GALMICHE, J. P, DORE, J

“…Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

IL-22BP is produced by eosinophils in human gut and blocks IL-22 protective actions during colitis by Martin, J C, Bériou, G, Heslan, M, Bossard, C, Jarry, A, Abidi, A, Hulin, P, Ménoret, S, Thinard, R, Anegon, I, Jacqueline, C, Lardeux, B, Halary, F, Renauld, J-C, Bourreille, A, Josien, R

“…Crohn’s disease and ulcerative colitis, the two major forms of inflammatory bowel diseases (IBDs), are characterized by high levels of IL-22 production. Rodent…”
Get full text

Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn’s disease: a randomised, double blind, placebo controlled GETAID trial by Marteau, P, Lémann, M, Seksik, P, Laharie, D, Colombel, J F, Bouhnik, Y, Cadiot, G, Soulé, J C, Bourreille, A, Metman, E, Lerebours, E, Carbonnel, F, Dupas, J L, Veyrac, M, Coffin, B, Moreau, J, Abitbol, V, Blum-Sperisen, S, Mary, J Y

“…Background and aims: Early endoscopic recurrence is frequent after intestinal resection for Crohn’s disease. Bacteria are involved, and probiotics may modulate…”
Get full text

Successive Treatment With Cyclosporine and Infliximab in Steroid-Refractory Ulcerative Colitis by Leblanc, S, Allez, M, Seksik, P, Flourié, B, Peeters, H, Dupas, J L, Bouguen, G, Peyrin-Biroulet, L, Duclos, B, Bourreille, A, Dewit, O, Bouhnik, Y, Michetti, P, Chaussade, S, Saussure, P, Mary, J Y, Colombel, J F, Lémann, M

“…Rescue therapy with either cyclosporine (CYS) or infliximab (IFX) is an effective option in patients with intravenous steroid-refractory attacks of ulcerative…”
Get full text

The triangular nasal notch sign in patients with Crohn disease treated with tumour necrosis factor inhibitors by Mesnard, C., Aubert, H., Bourreille, A., Trang, C., Gagey‐Caron, V., Le Corre, Y., Topin Ruiz, S., Barbarot, S.

Get full text

P1071 Patient preferences for adalimumab in inflammatory bowel disease: a nationwide study from the GETAID by Caron, B, Seksik, P, Buisson, A, Wils, P, Savoye, G, Stefanescu, C, Laharie, D, Guillo, L, Abitbol, V, Bonnet, J, Altwegg, R, Vuitton, L, Moussata, D, Bourreille, A, Biron, A, Gilletta, C, Fumery, M, Nahon, S, Nancey, S, Camara, H, Peyrin-Biroulet, L

“…Background Several adalimumab preparations are now available on the market for patients with inflammatory bowel disease. Comparative satisfaction and…”
Get full text

P679 Anti-TNF de-escalation following a treat-to-target strategy with golimumab therapy intensification to reach continuous clinical response in ulcerative colitis: the In-Target GETAID trial by Vuitton, L, Poullenot, F, Bouhnik, Y, Wils, P, Buisson, A, Viennot, S, Bouguen, G, Hébuterne, X, Gilletta, C, Nancey, S, Bourreille, A, Amil, M, Altwegg, R, Goutorbe, F, Caillo, L, Plastaras, L, Brixi, H, Simon, M, Serrero, M, Fumery, M, Rahier, J F, Vicaut, E, Peyrin-Biroulet, L

“…Abstract Background Achieving deep and continuous remission with tight control could allow de-escalation in patients with UC. The in-TARGET study was a…”
Get full text

Fistula Plug in Fistulising Ano-Perineal Crohn’s Disease: a Randomised Controlled Trial by Senéjoux, A., Siproudhis, L., Abramowitz, L., Munoz-Bongrand, N., Desseaux, K., Bouguen, G., Bourreille, A., Dewit, O., Stefanescu, C., Vernier, G., Louis, E., Grimaud, J. C., Godart, B., Savoye, G., Hebuterne, X., Bauer, P., Nachury, M., Laharie, D., Chevret, S., Bouhnik, Y.

“…Background and Aims: Anal fistula plug [AFP] is a bioabsorbable bioprosthesis used in ano-perineal fistula treatment. We aimed to assess efficacy and safety of…”
Get full text

Protocol of a multicentric prospective cohort study for the VALIDation of the IBD-disk instrument for assessing disability in inflammatory bowel diseases: the VALIDate study by Le Berre, C, Bourreille, A, Flamant, M, Bouguen, G, Siproudhis, L, Dewitte, M, Dib, N, Cesbron-Metivier, E, Goronflot, T, Hanf, M, Gourraud, P-A, Kerdreux, E, Poinas, A, Trang-Poisson, C

“…Inflammatory Bowel Diseases (IBD) affect psychological, family, social and professional dimensions of patients' life, leading to disability which is essential…”
Get full text

Wireless capsule endoscopy versus ileocolonoscopy for the diagnosis of postoperative recurrence of Crohn’s disease: a prospective study by Bourreille, A, Jarry, M, D’Halluin, P N, Ben-Soussan, E, Maunoury, V, Bulois, P, Sacher-Huvelin, S, Vahedy, K, Lerebours, E, Heresbach, D, Bretagne, J F, Colombel, J F, Galmiche, J P

“…Background and aims: Following ileocolonic resection for Crohn’s disease (CD), early endoscopic recurrence predicts recurrence of symptoms. The aim of the…”
Get full text

Neuro‐glial crosstalk in inflammatory bowel disease by Neunlist, M., Van Landeghem, L., Bourreille, A., Savidge, T.

“… Inflammatory bowel disease (IBD) is a multifactorial disease in which environmental, immune and genetic factors are involved in the pathogenesis. Although…”
Get full text

Modulation of VIPergic phenotype of enteric neurons by colonic biopsy supernatants from patients with inflammatory bowel diseases: Involvement of IL‐6 in Crohn's disease by Soufflet, F., Biraud, M., Rolli‐Derkinderen, M., Lardeux, B., Trang, C., Coron, E., Bruley des Varannes, S., Bourreille, A., Neunlist, M.

“…Background Neuroplastic changes in the enteric nervous system (ENS) observed during IBD might participate in physiopathological processes. Vasoactive…”
Get full text

Butyrate inhibits inflammatory responses through NFκB inhibition: implications for Crohn's disease by Segain, J-P, de la Blétière, D Raingeard, Bourreille, A, Leray, V, Gervois, N, Rosales, C, Ferrier, L, Bonnet, C, Blottière, H M, Galmiche, J-P

“…BACKGROUND/AIM Proinflammatory cytokines are key factors in the pathogenesis of Crohn's disease (CD). Activation of nuclear factor kappa B (NFκB), which is…”
Get full text

Association between entero‐hepatic Helicobacter species and Crohn’s disease: a prospective cross‐sectional study by LAHARIE, D., ASENCIO, C., ASSELINEAU, J., BULOIS, P., BOURREILLE, A., MOREAU, J., BONJEAN, P., LAMARQUE, D., PARIENTE, A., SOULÉ, J.‐C., CHARACHON, A., COFFIN, B., PEREZ, P., MÉGRAUD, F., ZERBIB, F.

“…Summary Background  The pathogenesis of Crohn’s disease (CD) involved microbial factors. Some Helicobacter species, the so‐called entero‐hepatic Helicobacters…”
Get full text

Infliximab for refractory ulcerative proctitis by BOUGUEN, G., ROBLIN, X., BOURREILLE, A., FEIER, L., FILIPPI, J., NANCEY, S., BRETAGNE, J.‐F., FLOURIÉ, B., HÉBUTERNE, X., BIGARD, M.‐A., SIPROUDHIS, L., PEYRIN‐BIROULET, L.

“…Aliment Pharmacol Ther 31, 1178–1185 Summary Background  Efficacy of infliximab in treating ulcerative proctitis remains unknown. Aim  To evaluate the…”
Get full text

Human intestinal circadian clock: expression of clock genes in colonocytes lining the crypt by Pardini, L, Kaeffer, B, Trubuil, A, Bourreille, A, Galmiche, J-P

“…Biological clock components have been detected in many epithelial tissues of the digestive tract of mammals (oral mucosa, pancreas, and liver), suggesting the…”
Get more information

Wireless capsule in Inflammatory Bowel Disease by Flamant, M., Trang, C., Bourreille, A.

“…Capsule endoscopy (CE) is a safe, non-invasive diagnostic tool to evaluate small bowel lesions. CE, like conventional endoscopy, can detect focal and…”
Get full text

P027 Involvement of PD-L1 in myenteric plexitis associated with postoperative recurrence of Crohn's disease by Le Berre, C, Durand, T, Clavreul, M, Neunlist, M, Bourreille, A, Neveu, I, Naveilhan, P

Get full text

Comparative Acceptability and Perceived Clinical Utility of Monitoring Tools: A Nationwide Survey of Patients with Inflammatory Bowel Disease by Buisson, Anthony, Gonzalez, Florent, Poullenot, Florian, Nancey, Stéphane, Sollellis, Elisa, Fumery, Mathurin, Pariente, Benjamin, Flamant, Mathurin, Trang-Poisson, Caroline, Bonnaud, Guillaume, Mathieu, Stéphane, Thevenin, Alain, Duruy, Marc, Filippi, Jérôme, Lʼhopital, François, Luneau, Fabrice, Michalet, Véronique, Genès, Julien, Achim, Anca, Cruzille, Emmanuelle, Bommelaer, Gilles, Laharie, David, Peyrin-Biroulet, Laurent, Pereira, Bruno, Nachury, Maria, Bouguen, Guillaume

“…Objective control of intestinal inflammation during inflammatory bowel disease (IBD) is becoming the main driver for medical treatment. However, the monitoring…”
Get full text